SCHMID HANS P 4
4 · SCICLONE PHARMACEUTICALS INC · Filed May 17, 2010
Insider Transaction Report
Form 4
SCHMID HANS P
Pres & Mng Dir, SciClone Int'l
Transactions
- Exercise/Conversion
Common Stock
2010-05-14$1.08/sh+35,000$37,800→ 55,000 total - Sale
Common Stock
2010-05-14$3.84/sh−55,000$211,233→ 0 total - Exercise/Conversion
Common Stock
2010-05-14$1.81/sh+20,000$36,200→ 20,000 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2010-05-14−35,000→ 90,000 totalExercise: $1.08Exp: 2019-03-06→ Common Stock (35,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2010-05-14−20,000→ 60,000 totalExercise: $1.81Exp: 2018-03-18→ Common Stock (20,000 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.8 to $3.89 inclusive.
- [F2]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F3]25% of such shares vest one year from the date of grant, of March 18, 2008, and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
- [F4]25% of such shares vest one year from the date of grant, of March 6, 2009, and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.